-
Hiroko SHIBATA
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
-
Tetsuya KAWAKITA
Daiichi Sankyo Co., Ltd.
-
Keisuke UCHIDA
Chugai Pharmaceutical Co., Ltd.
-
Aoi ARIYASU
Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited
-
Keisuke INOUE
Quality Control, Hikari Site Quality, Japan Quality, Global Quality, Takeda Pharmaceutical Company Limited
-
Jumpei EHARA
Laboratory for Chemistry, Manufacturing and Control, Asahi Kasei Pharma Corporation
-
Miho OGASAWARA
Analytical Research Labs, Pharmaceutical Technology, Astellas Pharma Inc.
-
Akihiro OKUDA
CMC RA Dept., Regulatory Affairs, GlaxoSmithKline K.K.
-
Yasuyo OZAKI
Regulatory CMC&License Dept., Regulatory Div., R&D, AstraZeneca K.K.
-
Dai SAKAMOTO
Analytical R&D, Ono Pharmaceutical Co., Ltd.
-
Akinao NIITUMA
Aizu Health Center
-
Kimiko MOCHIDA
Chugai Pharmaceutical Co., Ltd. The Pharmaceutical Manufacturers’ Association of Tokyo
-
Tatsuo KOIDE
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
-
Akiko ISHII-WATABE
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
-
Masato KIYOSHI
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
-
Akira HARAZONO
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
-
Mari TAKATSU
Pharmaceuticals and Medical Devices Agency
-
Yoshihiro MATSUDA
Pharmaceuticals and Medical Devices Agency
-
Yukio HIYAMA
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
